Annual CAPEX
$2.90 M
-$4.83 M-62.45%
31 December 2023
Summary:
Arcturus Therapeutics Holdings annual capital expenditures is currently $2.90 million, with the most recent change of -$4.83 million (-62.45%) on 31 December 2023. During the last 3 years, it has risen by +$1.16 million (+66.53%). ARCT annual CAPEX is now -62.45% below its all-time high of $7.73 million, reached on 31 December 2022.ARCT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$80.00 K
-$248.00 K-75.61%
30 September 2024
Summary:
Arcturus Therapeutics Holdings quarterly capital expenditures is currently $80.00 thousand, with the most recent change of -$248.00 thousand (-75.61%) on 30 September 2024. Over the past year, it has dropped by -$901.00 thousand (-91.85%). ARCT quarterly CAPEX is now -97.90% below its all-time high of $3.81 million, reached on 31 December 2022.ARCT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$1.52 M
-$901.00 K-37.17%
30 September 2024
Summary:
Arcturus Therapeutics Holdings TTM capital expenditures is currently $1.52 million, with the most recent change of -$901.00 thousand (-37.17%) on 30 September 2024. Over the past year, it has dropped by -$4.31 million (-73.89%). ARCT TTM CAPEX is now -80.29% below its all-time high of $7.73 million, reached on 31 December 2022.ARCT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARCT CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -62.5% | -91.8% | -73.9% |
| 3 y3 years | +66.5% | -95.5% | -49.0% |
| 5 y5 years | +96.3% | -49.7% | +109.2% |
ARCT CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -62.5% | +66.5% | -97.9% | +121.2% | -80.3% | at low |
| 5 y | 5 years | -62.5% | +254.7% | -97.9% | +121.2% | -80.3% | +109.2% |
| alltime | all time | -62.5% | +1074.5% | -97.9% | +121.2% | -80.3% | +882.6% |
Arcturus Therapeutics Holdings CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $80.00 K(-75.6%) | $1.52 M(-37.2%) |
| June 2024 | - | $328.00 K(+36.7%) | $2.42 M(-1.1%) |
| Mar 2024 | - | $240.00 K(-72.6%) | $2.45 M(-15.5%) |
| Dec 2023 | $2.90 M(-62.5%) | $875.00 K(-10.8%) | $2.90 M(-50.3%) |
| Sept 2023 | - | $981.00 K(+177.1%) | $5.83 M(-17.1%) |
| June 2023 | - | $354.00 K(-48.8%) | $7.04 M(+11.6%) |
| Mar 2023 | - | $691.00 K(-81.8%) | $6.31 M(-18.4%) |
| Dec 2022 | $7.73 M(+126.8%) | $3.81 M(+74.2%) | $7.73 M(+53.4%) |
| Sept 2022 | - | $2.19 M(-678.3%) | $5.04 M(+9.1%) |
| June 2022 | - | -$378.00 K(-117.9%) | $4.62 M(-14.5%) |
| Mar 2022 | - | $2.11 M(+88.8%) | $5.40 M(+58.5%) |
| Dec 2021 | $3.41 M(+95.5%) | $1.12 M(-36.7%) | $3.41 M(+14.1%) |
| Sept 2021 | - | $1.77 M(+337.1%) | $2.98 M(+80.6%) |
| June 2021 | - | $404.00 K(+242.4%) | $1.65 M(-3.8%) |
| Mar 2021 | - | $118.00 K(-83.1%) | $1.72 M(-1.4%) |
| Dec 2020 | $1.74 M | $697.00 K(+60.6%) | $1.74 M(+28.1%) |
| Sept 2020 | - | $434.00 K(-7.5%) | $1.36 M(+25.3%) |
| June 2020 | - | $469.00 K(+230.3%) | $1.08 M(+23.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $142.00 K(-54.9%) | $882.00 K(+7.8%) |
| Dec 2019 | $818.00 K(-44.7%) | $315.00 K(+98.1%) | $818.00 K(+12.4%) |
| Sept 2019 | - | $159.00 K(-40.2%) | $728.00 K(-11.4%) |
| June 2019 | - | $266.00 K(+241.0%) | $822.00 K(-31.2%) |
| Mar 2019 | - | $78.00 K(-65.3%) | $1.19 M(-19.2%) |
| Dec 2018 | $1.48 M(+488.8%) | $225.00 K(-11.1%) | $1.48 M(+5.3%) |
| Sept 2018 | - | $253.00 K(-60.3%) | $1.40 M(+13.7%) |
| June 2018 | - | $638.00 K(+76.2%) | $1.24 M(+101.8%) |
| Mar 2018 | - | $362.00 K(+139.7%) | $612.00 K(+143.8%) |
| Dec 2017 | $251.00 K(-63.5%) | $151.00 K(+79.8%) | $251.00 K(-66.8%) |
| Sept 2017 | - | $84.00 K(+460.0%) | $756.00 K(+11.3%) |
| June 2017 | - | $15.00 K(+1400.0%) | $679.00 K(+2.0%) |
| Mar 2017 | - | $1000.00(-99.8%) | $666.00 K(-3.2%) |
| Dec 2016 | $688.00 K(+178.5%) | $656.00 K(+9271.4%) | $688.00 K(+267.9%) |
| Sept 2016 | - | $7000.00(+250.0%) | $187.00 K(+3.9%) |
| June 2016 | - | $2000.00(-91.3%) | $180.00 K(+1.1%) |
| Mar 2016 | - | $23.00 K(-85.2%) | $178.00 K(+14.8%) |
| Dec 2015 | $247.00 K | $155.00 K | $155.00 K |
FAQ
- What is Arcturus Therapeutics Holdings annual capital expenditures?
- What is the all time high annual CAPEX for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual CAPEX year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly CAPEX year-on-year change?
- What is Arcturus Therapeutics Holdings TTM capital expenditures?
- What is the all time high TTM CAPEX for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings TTM CAPEX year-on-year change?
What is Arcturus Therapeutics Holdings annual capital expenditures?
The current annual CAPEX of ARCT is $2.90 M
What is the all time high annual CAPEX for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual capital expenditures is $7.73 M
What is Arcturus Therapeutics Holdings annual CAPEX year-on-year change?
Over the past year, ARCT annual capital expenditures has changed by -$4.83 M (-62.45%)
What is Arcturus Therapeutics Holdings quarterly capital expenditures?
The current quarterly CAPEX of ARCT is $80.00 K
What is the all time high quarterly CAPEX for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly capital expenditures is $3.81 M
What is Arcturus Therapeutics Holdings quarterly CAPEX year-on-year change?
Over the past year, ARCT quarterly capital expenditures has changed by -$901.00 K (-91.85%)
What is Arcturus Therapeutics Holdings TTM capital expenditures?
The current TTM CAPEX of ARCT is $1.52 M
What is the all time high TTM CAPEX for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high TTM capital expenditures is $7.73 M
What is Arcturus Therapeutics Holdings TTM CAPEX year-on-year change?
Over the past year, ARCT TTM capital expenditures has changed by -$4.31 M (-73.89%)